Testing a new drug for safety in healthy adults
This study tests a new medicine called SAB01 in healthy adults to see if it is safe and how the body handles it. It is a first-in-human trial, meaning this is the first time the drug is given to people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 55 years old.
- You must not smoke or use tobacco, and if you used to smoke, you must have quit at least 6 months before screening.
- You must have a body mass index (BMI) between 18 and 32, and weigh no more than 100 kg (about 220 lbs).
- You must not have any serious medical conditions, and you must have normal blood tests, including a tryptase level (a marker for allergy).
- You must not have a history of severe allergies, asthma, or anaphylaxis.
- You must avoid taking most prescription and over-the-counter medications, vitamins, or herbal supplements for at least 7 days before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug, SBS-147, in healthy adults to see if it's safe and how the body processes it. It may help find the right dose for future studies in people with certain conditions.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This study tests a new investigational medicine called SSS67, given as a one-time IV infusion. It is an early-phase trial in healthy volunteers to check how safe the drug is and how the body handles it, and it may help researchers decide if it can be developed for future conditions.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This trial tests a new medicine (called 627) in healthy adults to see if it is safe and how the body handles it. It may help future treatment development.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
Hear when a new Healthy Adult Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.